Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients
Conditions
Biliary Tract Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU Amiens Picardie, Amiens, France
Contact: Study coordinator (Vincent HAUTEFEUILLE) · hautefeuille.vincent@chu-amiens.fr · +33(0)322088854Institut de cancerologie de l'Ouest - Angers, Angers, France
Contact: Study coordinator (Victor SIMMET) · victor.simmet@ico.unicancer.mssante.fr · +33(0)241352700Institut du Cancer Avignon Provence, Avignon, France
CHU Besançon, Besançon, France
CHU de Bordeaux - Hôpital Haut-Leveque, Bordeaux, France
Contact: Study coordinator (Jean-Frédéric BLANC) · jean-frederic.blanc@chu-bordeaux.fr · +33(0)557656439Centre François Baclesse, Caen, France
Contact: Study coordinator (Stéphane CORBINAIS) · s.corbinais@baclesse.unicancer.fr · +33(0)231455002Centre Jean Perrin, Clermont-Ferrand, France
Contact: Study coordinator (Florence OSAER) · Florence.OSAER@clermont.unicancer.fr · +33(0)473278080CHU Estaing de Clermont Ferrand, Clermont-Ferrand, France
APHP - Hôpital Beaujon, Clichy, France
APHP - Hopital Henri Mondor, Créteil, France
Contact: Study coordinator (Christophe TOURNIGAND) · christophe.tournigand@aphp.fr · +33(0)149812567CHU de Dijon, Dijon, France
Groupe hospitalier mutaliste de Grenoble - Institut Daniel Hollard, Grenoble, France
Centre Oscar Lambret, Lille, France
Chu Lille, Lille, France
CHU Dupuytren, Limoges, France
Contact: Study coordinator (Frédéric THUILLIER) · frederic.thuillier@chu-limoges.fr · +33(0)555087292Centre Leon Bérard, Lyon, France
Contact: Study coordinator (Philippe CASSIER) · philippe.cassier@lyon.unicancer.fr · +33(0)426556833APHM - CHU La Timone, Marseille, France
Hopital Saint Joseph, Marseille, France
Institut Paoli Calmettes, Marseille, France
Institut de Cancer de Montpellier, Montpellier, France
Contact: Study coordinator (Fabienne PORTALES) · fabienne.portales@icm.unicancer.fr · +33(0)467612353CHRU de Nancy, Nancy, France
CHU Nantes - Hôtel Dieu, Nantes, France
Hôpital du Confluent Nantes, Nantes, France
Centre Antoine Lacassagne, Nice, France
APHP - Hôpital Saint Antoine, Paris, France
Institute Mutualiste Montsouris, Paris, France
Contact: Study coordinator (David MALKA, MD)Contact: Principal Investigator (David MALKA, MD)CH de Pau, Pau, France
CHU Poitiers, Poitiers, France
CH Cornouaille, Quimper, France
CHU de Reims, Reims, France
Institut Jean Godinot, Reims, France
Centre Eugène Marquis, Rennes, France
Contact: Study coordinator (Julien Edeline)Contact: Principal Investigator (Julien Edeline, MD)CHU Charles Nicolle, Rouen, France
Institut Curie - Saint Cloud, Saint-Cloud, France
Institut de cancerologie de l'Ouest - St Herblain, Saint-Herblain, France
Hôpital Foch, Suresnes, France
CHU Toulouse, Toulouse, France
CH Valence, Valence, France
APHP - Hôpital Paul Brousse, Villejuif, France
Gustave Roussy, Villejuif, France
University College London, London, United Kingdom
Contact: Study coordinator (John BRIDGEWATER, MD)Contact: Principal Investigator (John BRIDGEWATER, MD)
Study leads
Julien Edeline, MD
Principal Investigator
Centre Eugène Marquis
Ivan Borbath, MD
Principal Investigator
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
John Bridgewater, MD
Principal Investigator
University College London Cancer Institute
David Malka, MD
Principal Investigator
Institut Mutualiste Montsouris